EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS134-24662 
Organism
Homo sapiens 
Tissue/cell
Mesendoderm 
Coordinate
chr17:45949420-45951250 
Target genes
SNPs
Number: 1             
IDChromosomePositionGenome Version
rs72833470chr1745950721hg19
TF binding sites/motifs
Number: 23             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:45951180-45951198CCCTCCCTCCCCCCTTCC-6.17
EWSR1-FLI1MA0149.1chr17:45951192-45951210CCTTCCTTCCTTCTTGCT-6.56
EWSR1-FLI1MA0149.1chr17:45951196-45951214CCTTCCTTCTTGCTTTCC-6.57
EWSR1-FLI1MA0149.1chr17:45951188-45951206CCCCCCTTCCTTCCTTCT-6.68
EWSR1-FLI1MA0149.1chr17:45951184-45951202CCCTCCCCCCTTCCTTCC-7.05
RUNX1MA0002.2chr17:45950409-45950420AAACCACAGAG-6.14
SNAI2MA0745.2chr17:45949542-45949552AACAGGTGCA+6.02
SPICMA0687.1chr17:45949447-45949461GAAAAGGGGAAGAA+6.09
ZBTB18MA0698.1chr17:45949557-45949570TGTCCAGATGTTG+6.05
ZNF263MA0528.1chr17:45951205-45951226TTGCTTTCCTCCTCCTCCTCC-6.45
ZNF263MA0528.1chr17:45951214-45951235TCCTCCTCCTCCTCTTCTTCT-6.54
ZNF263MA0528.1chr17:45951229-45951250TCTTCTTCCTCCTCCCCCTCC-6.6
ZNF263MA0528.1chr17:45951199-45951220TCCTTCTTGCTTTCCTCCTCC-6.93
ZNF263MA0528.1chr17:45951168-45951189TCTTCTCTCTCTCCCTCCCTC-7.17
ZNF263MA0528.1chr17:45951217-45951238TCCTCCTCCTCTTCTTCTTCC-7.19
ZNF263MA0528.1chr17:45951172-45951193CTCTCTCTCCCTCCCTCCCCC-7.38
ZNF263MA0528.1chr17:45951184-45951205CCCTCCCCCCTTCCTTCCTTC-7.41
ZNF263MA0528.1chr17:45951211-45951232TCCTCCTCCTCCTCCTCTTCT-7.64
ZNF263MA0528.1chr17:45951180-45951201CCCTCCCTCCCCCCTTCCTTC-7.8
ZNF263MA0528.1chr17:45951226-45951247TCTTCTTCTTCCTCCTCCCCC-8.51
ZNF263MA0528.1chr17:45951208-45951229CTTTCCTCCTCCTCCTCCTCT-8.86
ZNF263MA0528.1chr17:45951220-45951241TCCTCCTCTTCTTCTTCCTCC-8.92
ZNF263MA0528.1chr17:45951223-45951244TCCTCTTCTTCTTCCTCCTCC-9.79
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_56052chr17:45949190-45951084u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr174595007945950294
Number: 1             
IDChromosomeStartEnd
GH17I047872chr174594947345951118
Enhancer Sequence
ATAGGTAAAC AAGTGGTTGA AAAATAGGAA AAGGGGAAGA AAAAAAGAGA AGCTATCATG 60
GGGTGTTTTC TCCCAGGTAT CAGGGTCGCA GGTAGTTCCA ACCTCAACTG GGAACAAGTC 120
CCAACAGGTG CAACCCCTGT CCAGATGTTG CACAATGCAG GCGCGTGCCC AGAGCCCAAT 180
CCCAGATCGG TTCTCGGGCA GAGGTCCGGG TTGGGGATGT ATCCAAACCA GAAATATCCT 240
TTCAGGTCTC TCTCCCCGAG ACAAACCCCG GCAGGGTCTG CTCCTCCCGG AGCCGGCTTG 300
CAGGCGTGTT GGGGGAAGCC AGCGAGGTTG TTTGCCGGGA AAGGACAGTT TGGGACCCGG 360
GAGGGGAGTT CCCTGCGTCT GGGCCGTGGG GGGAGCTACA GGCCGGGCGG GGGTGAGTAA 420
GGCCCAGCGG ACGCAGGAGG CTCAGTGGCG GCGGCGGCGG CGGCGATGGG GAGGAGGGTA 480
ATTAGCAGGG AGGCTCTCGC CACAGCACGT CCCCACAAAT GAGAGGCCCC GGGCCCCAGA 540
CACCACACAA CAAAGCAAGA GGCAATTATT TGGCTCCAGT GGGAGGGGAC AGCCCTTTGC 600
CGGCCCACTG CAGCTGAGCA CCCAGCCTCC GTTGAGGACG CGGAGGGTGG GGTGCAGAGA 660
CCCCTCTCAC CAGCCCCCCG GCGGCAAGGG CAGGGCCCCG AGGGACTCCC GCTGGGTTAC 720
CCTTAGAGGA GGTCCCTGTT TGGGAAGGCA GAGCCGTAGG AGGCCCCAGC CTGATTAGAG 780
CCGGCCCTCA GCCAGCCCGG AGCCTCCCAC AAGGCATCCA GGAGACCTCC TGGGGACCCC 840
ACAGGGAAGC GAGAATGTCC TGGGACCGGG GCTGGAGAGG GCGGAAGGGG CTTTTTGGGT 900
CCTGGAGAAG CCAGTGGCCA ACATCTGAAC CCCCCTTCTC CAGCTGTGGC CACACAACTG 960
GCAACCGGGA GGCTCTCAGG CAGGTGGGGA AACCACAGAG GAGGGAGCAG GAGCCAGGGA 1020
GATTCCAGAG CTCTGGCCTA GACCTGGAAT TCACACAATT GCTATGCAAA CCAAATGCAA 1080
ATACATCTTC TTTTATCTCC CCTTCAAAAA TCGTCAAATC AAGCATATTT GGAAGAAGGC 1140
CAGGCCTGAT CAGCTGGAGG ACCCCCAGCC TCTGCTTGCC TCCTTCTCCC TTTCCACCCA 1200
CCCATCCCTA CAGGAAAACT AAGTCCTACA ATACCTTAGA TTCACCTGGG ACCCATCTGC 1260
AAAGGACTTT CCCCTCTTCA GATGAAAGAG CCCAAAGTAC AGATGGGGAA AAAGAGGCCT 1320
TAAGAGATTA AGGTACTTTC CCCTGCCCTA ACAGCCCACC TGGAGAATGA CAGGCCTCCT 1380
GGAAGCTTCT GACAACAGCC CTAGGTTAAC AGCATGCCAG CTGGGGGAGG GGAAAGAGCA 1440
CAGAACTGGG AGTCCTAAAA TCTGATCTCT GGTCTCAGCT TTGCCTCTAA CTTGCTGGGT 1500
AATCTTGAGA GAGTTACTTA TCTTCTCCAA GCCTCAATTT CTCTGAATAT CAAGTGGCTA 1560
TCTCTGGGAA AAAAGGCTCT TCCCGAGTTG AGCCCCTCCC TGCGTCAGGG CCATCCCGCA 1620
TTGCTGCCAA GGGTCCTTGA GCCAAATGCT CTGCTTGTCA TCCTCCCCAG CTCTCACCAC 1680
TCTCTGCCTC AGGCCAACAT AGGATGAACC CCAGCCATTG GCCTCCCCTT TTCTTTTCTC 1740
TTTTCTTCTC TTCTCTCTCT CCCTCCCTCC CCCCTTCCTT CCTTCTTGCT TTCCTCCTCC 1800
TCCTCCTCTT CTTCTTCCTC CTCCCCCTCC 1830